ctrl K

Price Alert

Tonix Pharmaceuticals Hol... (TNXP)

NASDAQ: TNXP · Real-Time Price · USD

51.66

-7.92 (-13.29%)

At close: Aug 15, 2025, 1:03 PM

Tonix Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	98.78M	24.95M	120.23M	178.66M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	904K	n/a	241K	240K
Other Long-Term Assets	47K	1.13M	143K	259K
Receivables	7.9M	4.59M	n/a	7.73M
Inventory	8.41M	14.15M	-8.04M	-7.73M
Other Current Assets	3.91M	2.43M	1.23M	1.18M
Total Current Assets	119M	47.77M	130.78M	189.05M
Property-Plant & Equipment	42.82M	94.85M	94.53M	51.47M
Goodwill & Intangibles	120K	10.71M	120K	120K
Total Long-Term Assets	43.89M	106.69M	94.91M	51.85M
Total Assets	162.89M	154.46M	225.69M	240.9M
Account Payables	4.55M	3.78M	8.07M	13.28M
Deferred Revenue	n/a	2.98M	3.27M	2.83M
Short-Term Debt	3.09M	2.35M	n/a	n/a
Other Current Liabilities	6.04M	5.14M	2.76M	2.25M
Total Current Liabilities	18.31M	18.88M	18.18M	21.72M
Long-Term Debt	4.67M	6.56M	n/a	n/a
Other Long-Term Liabilities	n/a	22.86M	n/a	n/a
Total Long-Term Liabilities	5.03M	30.05M	328K	467K
Total Liabilities	23.33M	48.93M	18.51M	22.18M
Total Debt	8.12M	9.81M	760K	956K
Common Stock	4K	59K	76K	496K
Retained Earnings	-730.69M	-600.66M	-470.04M	-359.82M
Comprehensive Income	-255K	-232K	-167K	-92K
Shareholders Equity	139.56M	105.53M	207.18M	218.72M
Total Investments	904K	900K	241K	240K